(Q53140391)

11 May 2018

title

(18)F-FDG uptake at initial staging of the adrenocortical cancers: a diagnostic tool but not of prognostic value. (English)

1 reference

11 May 2018

author

Julien Mancini

11

1 reference

11 May 2018

author name string

L Tessonnier

1

1 reference

11 May 2018

C Ansquer

2

1 reference

11 May 2018

C Bournaud

3

1 reference

11 May 2018

F Sebag

4

1 reference

11 May 2018

E Mirallié

5

1 reference

11 May 2018

J C Lifante

6

1 reference

11 May 2018

F F Palazzo

7

1 reference

11 May 2018

I Morange

8

1 reference

11 May 2018

D Drui

9

1 reference

11 May 2018

C de la Foucardère

10

1 reference

11 May 2018

D Taïeb

12

1 reference

11 May 2018

publication date

1 January 2013

1 reference

11 May 2018

published in

World Journal of Surgery

1 reference

11 May 2018

volume

37

1 reference

11 May 2018

issue

1

1 reference

11 May 2018

page(s)

107-112

1 reference

11 May 2018

Adrenocortical carcinoma: a clinician's update

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00268-012-1802-Y

The use of FDG-PET and CT for the staging of adrenocortical carcinoma in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-012-1802-Y

Positron emission tomography imaging of adrenal masses: (18)F-fluorodeoxyglucose and the 11beta-hydroxylase tracer (11)C-metomidate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-012-1802-Y

Use of [18F]fluorodeoxyglucose positron emission tomography in evaluating locally recurrent and metastatic adrenocortical carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-012-1802-Y

Does 18F-FDG PET/CT add diagnostic accuracy in incidentally identified non-secreting adrenal tumours?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-012-1802-Y

18F-Fluorodeoxyglucose positron emission tomography for the diagnosis of adrenocortical tumors: a prospective study in 77 operated patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-012-1802-Y

18F-FDG PET for the identification of adrenocortical carcinomas among indeterminate adrenal tumors at computed tomography scanning

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-012-1802-Y

18F-FDG PET/CT in the characterization and surgical decision concerning adrenal masses: a prospective multicentre evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-012-1802-Y

Characterization of adrenal masses by using FDG PET: a systematic review and meta-analysis of diagnostic test performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-012-1802-Y

Diagnostic and prognostic value of 18-fluorodeoxyglucose positron emission tomography in adrenocortical carcinoma: a prospective comparison with computed tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-012-1802-Y

Glucose transporter GLUT1 expression is an stage-independent predictor of clinical outcome in adrenocortical carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-012-1802-Y

FDG PET in the management of patients with adrenal masses and adrenocortical carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-012-1802-Y

Early interim 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography is prognostically superior to international prognostic score in advanced-stage Hodgkin's lymphoma: a report from a joint Italian-Danish study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-012-1802-Y

[18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in aggressive lymphoma: an early prognostic tool for predicting patient outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-012-1802-Y

Primary tumor standardized uptake value measured on fluorodeoxyglucose positron emission tomography is of prognostic value for survival in non-small cell lung cancer: update of a systematic review and meta-analysis by the European Lung Cancer Workin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-012-1802-Y

Prognostic value of 18F-FDG PET in patients with head and neck squamous cell cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-012-1802-Y

The clinical application of (18)F-fluorodeoxyglucose positron emission tomography to predict survival in patients with operable esophageal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-012-1802-Y

Understanding the Warburg effect: the metabolic requirements of cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-012-1802-Y

Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-012-1802-Y

The standardized uptake value for F-18 fluorodeoxyglucose is a sensitive predictive biomarker for cervical cancer treatment response and survival

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23001287

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Imaging of adrenal incidentalomas with PET using (11)C-metomidate and (18)F-FDG.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23001287

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00268-012-1802-Y

1 reference

11 May 2018

1 reference

11 May 2018